Why does null hypothesis testing matter for target validation in host-pathogen proteomics?

Null hypothesis testing, such as Student's T test corrected for multiple hypothesis testing using Benjamini-Hochberg FDR, is used to identify proteins with significant abundance changes during infection versus non-infected controls. This statistical rigor ensures that observed differences in fungal virulence factors or host response proteins are not due to random variation, increasing confidence in target validity.

How does independent variable isolation fit the discovery pipeline in this workflow?

Independent variable isolation is achieved by optimizing multiplicity of infection (MOI) and time points for each pathogen-host pair, ensuring that observed proteomic changes are attributable to infection status rather than culture variability. This standardization supports reproducible discovery-phase experiments and enables reliable comparison across conditions in target validation studies.

What quantitative dependent variable measurements enable target prioritization in this proteomics approach?

Label-free quantification (LFQ) provides quantitative measurements of protein abundance changes, enabling the identification of differentially expressed fungal and host proteins during infection. These quantitative outputs, such as the 117 significantly altered host proteins identified, allow teams to prioritize targets based on fold-change magnitude and statistical significance.

Why do replication requirements matter for cross-functional collaboration in infection proteomics?

Replication requirements, demonstrated by the 95% to 96% replicate reproducibility in clustering and PCA analysis, ensure that proteomic profiles are consistent across experiments, which is essential for cross-functional teams to trust and build upon shared data. High reproducibility supports collaborative target validation and assay development by minimizing variability between laboratories or study phases.

What statistical analysis capabilities are required before implementing this workflow for target discovery?

Before implementation, teams require capabilities to perform principal component analysis (PCA), hierarchical clustering by Euclidean distance, and Student's T test with Benjamini-Hochberg false discovery rate correction to identify significantly altered proteins. These analytical steps are necessary to distinguish infection-specific signals from biological variability and ensure robust target identification.